Bivalirudin for patients with acute coronary syndromes - Wikidata - awgldk - TriplyDB

Bivalirudin for patients with acute coronary syndromes

Bivalirudin for patients with acute coronary syndromes

http://www.wikidata.org/entity/Q28210982

about

Reappraisal of thienopyridine pretreatment in patients with non-ST elevation acute coronary syndrome: a systematic review and meta-analysis Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes Early invasive versus conservative strategies for unstable angina and non-ST elevation myocardial infarction in the stent era Management of patients with unstable angina / non-ST-elevation myocardial infarction: a critical review of the 2007 ACC /AHA guidelines Routine invasive strategies versus selective invasive strategies for unstable angina and non-ST elevation myocardial infarction in the stent era Acute management of unstable angina and non-ST segment elevation myocardial infarction Bivalirudin Anticoagulant Therapy With or Without Platelet Glycoprotein IIb/IIIa Inhibitors During Transcatheter Coronary Interventional Procedures: A Meta-Analysis Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis The REG1 anticoagulation system: a novel actively controlled factor IX inhibitor using RNA aptamer technology for treatment of acute coronary syndrome Perspectives on the 2014 ESC/EACTS Guidelines on Myocardial Revascularization : Fifty Years of Revascularization: Where Are We and Where Are We Heading?Platelet glycoprotein IIb/IIIa blockers for percutaneous coronary revascularization, and unstable angina and non-ST-segment elevation myocardial infarction Anticoagulation in the management of non-ST-segment elevation acute coronary syndrome.Selecting the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous coronary intervention.Acute coronary syndromes: diagnosis and management, part I Heparin-induced thrombocytopenia: treatment options and special considerations.Percutaneous coronary intervention in patients with acute coronary syndrome: focus on bivalirudin The direct thrombin inhibitor argatroban: a review of its use in patients with and without HIT.The Role of Glycoprotein IIb/IIIa Inhibitors- A Promise Not Kept?Actual Role of Platelet Glycoprotein IIb/IIIa Receptor Inhibitors as Adjunctive Pharmacological Therapy to Primary Angioplasty in Acute Myocardial Infarction: In the Light of Recent Randomized Trials and Observational Studies with Bivalirudin.Bivalirudin: a review of the pharmacology and clinical application.New and emerging anticoagulant therapy for atrial fibrillation and acute coronary syndrome.Safety of bivalirudin in patients with coronary artery disease.Evaluation of dose requirements for prolonged bivalirudin administration in patients with renal insufficiency and suspected heparin-induced thrombocytopenia.Bivalirudin for primary percutaneous coronary intervention in acute myocardial infarction: the HORIZONS-AMI trial.Predicting and evaluating the effect of bivalirudin in cardiac surgical patients.A Predictive Model for the Anticoagulant Bivalirudin Administered to Cardiac Surgical Patients.Bivalirudin for Alternative Anticoagulation in Extracorporeal Membrane Oxygenation: A Systematic Review.Risk of thrombocytopenia with glycoprotein IIb/IIIa inhibitors across drugs and patient populations: a meta-analysis of 29 large placebo-controlled randomized trials.Efficiency and safety of bivalirudin in patients undergoing emergency percutaneous coronary intervention via radial access: A subgroup analysis from the bivalirudin in acute myocardial infarction versus heparin and GPI plus heparin trial.Successful use of bivalirudin in place of heparin infusion for pulmonary vein isolation using a cryoballoon catheter in a patient with heparin allergy.Recent advances in antithrombotic therapy after acute coronary syndrome.Safety and effectiveness of bivalirudin in routine care of patients undergoing percutaneous coronary intervention Safety and efficacy of abciximab as an adjunct to percutaneous coronary intervention.Has the frequency of bleeding changed over time for patients presenting with an acute coronary syndrome? The global registry of acute coronary events Fondaparinux and acute coronary syndromes: update on the OASIS 5-6 studies.Population pharmacokinetics and pharmacodynamics of bivalirudin in young healthy Chinese volunteers.Temporal trends in percutaneous coronary intervention--associated acute cerebrovascular accident (from the 1998 to 2008 Nationwide Inpatient Sample Database).Use of platelet glycoprotein IIb/IIIa inhibitors in diabetics undergoing PCI for non-ST-segment elevation acute coronary syndromes: impact of clinical status and procedural characteristics.

P2860

Q22242057-F6D0A271-0B79-468E-8B19-2D78E9342931 Q24202522-03AFACFB-6BC4-4322-AAF3-FA8588F7D085 Q24202999-827059B7-AFAD-4C75-AFEB-809AFE89C046 Q24235385-904CCA21-81F2-4F62-92B6-EC161C25AC94 Q24236794-4D84427A-D3DD-423E-9A95-C54F7A177BEB Q24653318-B7F27C7E-0DFD-46AF-9510-73BCD42959EE Q26471900-DC1E6205-442D-45A6-A4CC-29770A99F9D8 Q26783157-9A3935A3-B382-4775-A3E2-E74045CC687B Q26798653-A12A736E-F22C-40BF-AC89-A3303AACBE5E Q26853150-AF6D4F04-3173-4027-8827-B0D25F4D4C43 Q27000201-92DBC185-EDFF-495A-B933-3788C3FE0BFC Q28087099-606AFB8F-2B7D-41F7-8DDC-E311C4CDCB14 Q28191096-036E1576-F14D-4E05-B120-75A33C5DEE2F Q30402038-0C74FE45-C3B4-4F8D-B916-B3E3837398A6 Q30438893-51881B8E-3D32-4592-83AA-4FC1AC85CC86 Q30490718-1AA98A39-D472-405A-B667-215881695262 Q33374658-3FC4FE09-9C26-498F-BC9E-5B1E94544315 Q33381356-C3FCA018-1390-40B9-8D52-A6F50EA0C97B Q33385970-A7A0B465-EC60-47A9-9815-3DDD5378D41D Q33387192-0D09D5A8-8079-48C4-936F-AB16526A5CD2 Q33391341-6A6D981A-AC91-4DC2-8C74-048F278345E9 Q33392973-81F75620-396E-453E-9D57-30A002BC0635 Q33397359-999759C4-DCA8-43B8-B55A-4FA4F193CB33 Q33397635-76887DF8-63B8-4471-BCEE-8E98DEA67E19 Q33399307-4989F8D8-FD9D-4FDD-A8A3-90D4302DF447 Q33400450-65C4E937-A097-4AA2-8CF1-5265C5FBA8BD Q33410211-2A333D70-0F3C-47A6-9C4A-411DB94A19B2 Q33414958-8241B706-BFA9-45E2-B2D1-232725E32FBD Q33433514-CD4A228A-FB97-4388-BFEB-1C0B39890D66 Q33434702-304921F3-7A72-4909-BA67-1EA45E503487 Q33435616-8E1D2FB8-A7A6-4990-9325-64B229ED370D Q33441751-5F34020A-9397-4E0D-89D7-E9EF40C49BB1 Q33590548-2B17DF51-C0A4-4D2E-9946-DB979306BACA Q33701953-E8D7F4CB-9F5A-4E62-97A4-C7A30A63FA7F Q33715389-277E000F-FF1F-45BA-ACB4-1A8AC8A827A1 Q33728256-6C398954-C10B-40C6-AC66-22DE7D451A9E Q33797609-4CF686C9-9680-4E99-B56B-C7549C2FFC75 Q33824750-A8C0C30C-EE38-4DAD-997A-DDBBB38C3940 Q33874044-4097D7B6-CD2C-48A9-B7AF-DEC392EED701 Q33876187-CFB203F8-B777-4B28-ADFD-CFC7A7F34502

P2860

Bivalirudin for patients with acute coronary syndromes

http://www.wikidata.org/entity/Q28210982

description

2006 nî lūn-bûn

@nan

2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Bivalirudin for patients with acute coronary syndromes

@ast

Bivalirudin for patients with acute coronary syndromes

@en

Bivalirudin for patients with acute coronary syndromes

@nl

type

label

Bivalirudin for patients with acute coronary syndromes

@ast

Bivalirudin for patients with acute coronary syndromes

@en

Bivalirudin for patients with acute coronary syndromes

@nl

prefLabel

Bivalirudin for patients with acute coronary syndromes

@ast

Bivalirudin for patients with acute coronary syndromes

@en

Bivalirudin for patients with acute coronary syndromes

@nl

P1433

Q28210982-CC7BD89E-1BB3-4636-8888-4B84FDAA71F3

P1476

Q28210982-8A9DB762-C229-47CB-92B9-E8BF5D1466EC

P2093

Q28210982-14CE5989-29E6-4C3C-A547-DB29A785E935

Q28210982-155C1307-9913-446C-A96D-9CABA2284DFF

Q28210982-21DD6C2C-B625-44EA-AF2F-AFC91CDCBFA8

Q28210982-229CB1F3-06D4-42C5-84C3-4BB06F1A2B22

Q28210982-264418AE-2521-49BB-AEA4-9960A0927E72

Q28210982-38593205-DCD7-4035-9110-8D41DC8CBE83

Q28210982-3A79A8F0-0230-46F3-8966-884E45412F85

Q28210982-41D320DB-2505-4479-82E1-72DC020CBFAF

Q28210982-4B95188E-AA5B-473C-BEC6-465A8358C296

Q28210982-52BE978C-8C5A-4742-B6F8-AAC4F30E533C

P304

Q28210982-E0048E77-9552-4FB7-98D1-A01C10D8819B

P31

Q28210982-C7D1D9B4-516F-42F0-BA2E-D0C94D617368

P3181

Q28210982-A0246EF0-EAAE-4F75-91B3-58727D0781D1

P356

Q28210982-9CF683F3-207C-4FEC-AF9D-623BD258B16D

P407

Q28210982-0C05C73F-8A80-4052-AE11-8D3318E2E4B5

P433

Q28210982-CF3798F6-6DDB-4BB2-9B1C-DFDAE14C634A

P478

Q28210982-EC0E8E08-D901-4429-A6AF-C7E6CB1914DF

P50

Q28210982-19505769-8D08-4188-AD72-C36B0337813B

Q28210982-88A41164-9A98-48DF-81AD-17709F3952D6

Q28210982-AB5CDDE7-9C43-4D7B-9DAD-A692FE4C916B

P577

Q28210982-EBC55E7E-A952-4EE5-A099-65A68B08825A

P698

Q28210982-BCD93335-0F34-499B-80B2-07A62129EA60

P3181

P356

P1433

The New England Journal of Medicine

P1476

Bivalirudin for patients with acute coronary syndromes

@en

P2093

Angel R Cequier

http://www.w3.org/2001/XMLSchema#string

Antonio Colombo

http://www.w3.org/2001/XMLSchema#string

Brent T McLaurin

http://www.w3.org/2001/XMLSchema#string

David A Cox

http://www.w3.org/2001/XMLSchema#string

Frederick Feit

http://www.w3.org/2001/XMLSchema#string

Gregg W Stone

http://www.w3.org/2001/XMLSchema#string

Hans-Jürgen Rupprecht

http://www.w3.org/2001/XMLSchema#string

Harald Darius

http://www.w3.org/2001/XMLSchema#string

Harvey D White

http://www.w3.org/2001/XMLSchema#string

James H Ware

http://www.w3.org/2001/XMLSchema#string

P304

2203-16

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3564389

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJMOA062437

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

355

http://www.w3.org/2001/XMLSchema#string

P50

Erik Magnus Ohman

A Michael Lincoff

P577

2006-11-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17124018

http://www.w3.org/2001/XMLSchema#string